🚨 Rapid vs standard taper for immune checkpoint inhibitor #AIN.
Tweetorial on our study which is out on @jitcancer#onconephrology @MegSise @MGHKidneys @MGHCancerCenter
New Review online! Kidney injury and disease in patients with haematological malignancies, including injury caused by monoclonal gammopathies, tumour and paraneoplastic disorders, and anti-cancer treatment. https://t.co/OnHV2saISr #onconephrology
Immunofluorescence Staining for Immunoglobulin Heavy Chain/Light Chain on Kidney Biopsies is a Valuable Ancillary Technique For the Diagnosis of Monoclonal Gammopathy-Associated Kidney Diseases https://t.co/J1rBGTsV4q #renalpath@Kidney_Int@MayoClinicNeph@MayoClinicPath
In this pilot study of patients with proliferative GN with monoclonal immunoglobulin deposition, the monoclonal anti-CD38 antibody daratumumab exhibited an acceptable safety profile and improvement in proteinuria while stabilizing kidney function https://t.co/JBFokPVnRI
A study of a large cohort of adult survivors of childhood cancer found that 2.1% had stage 3–5 CKD, which was associated with treatment ever with a calcineurin inhibitor, cumulative dose of some chemotherapy agents, kidney irradiation, and other factors https://t.co/CZ2SqPruOB
This Review Article by Biruh T. Workeneh, Nupur N. Uppal, @kdjhaveri and @NephroMD summarizes magnesium physiology and highlights the mechanisms underlying magnesium disturbances due to cancer and cancer treatment. https://t.co/JytfJ2dWOk @MDAndersonNews@HofNorthwellDOM@UPMC
Risk for significant kidney function decline after acute kidney injury in adults with hematologic malignancy
#AKI#openaccess@KIReports
https://t.co/hIK1jF9Ynp
Our latest....Renal failure in over 20% of pts using carfilzomib in real world, need more insight into causes with @tanyawildes
https://t.co/ZlzCCLdR8E
An individualized approach, with collaboration between oncologists, urologists and nephrologists is needed for many patients with CKD who may be candidates for cisplatin treatment #onconephrology @NephroGuy
Should we do kidney transplant in amyloidosis?
We have recently started - so this is quite reassuring,
From the amyloid folks at @RenalUCL in @NDTsocial https://t.co/lNCFbyJGqb